Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 159,588 251,929 319,053 656,089
Total Sell Value $13,270,852 $21,508,551 $27,661,182 $61,420,002
Total People Sold 5 6 7 7
Total Sell Transactions 10 19 27 56
End Date 2024-03-24 2023-12-22 2023-06-23 2022-06-23

   
Records found: 1285
  Page 3 of 52  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mueller Brian EVP, Chief Financial Officer   •       –      –    2024-03-15 4 A $0.00 $0 D/D 11,400 92,648     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2024-03-15 4 D $83.87 $1,893,785 D/D (22,580) 71,467     -
   Guyer Charles Greg EVP, Chief Technical Officer   •       –      –    2024-03-15 4 D $83.87 $1,712,961 D/D (20,424) 78,327     -
   Guyer Charles Greg EVP, Chief Technical Officer   •       –      –    2024-03-15 4 A $0.00 $0 D/D 10,550 98,751     -
   Bienaime Jean Jacques Director   –       •      –    2024-03-06 4 S $86.71 $86,713 D/D (1,000) 560,203     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2024-03-05 4 AS $87.07 $348,280 D/D (4,000) 94,047     -
   Fuchs Henry J President, Worldwide R&D   •       –      –    2024-03-05 4 S $85.18 $3,010,396 D/D (35,341) 212,117     -
   Bienaime Jean Jacques Director   –       •      –    2024-03-05 4 S $85.51 $85,510 D/D (1,000) 561,203     -
   Guyer Charles Greg EVP, Chief Technical Officer   •       –      –    2024-02-27 4 A $0.00 $0 D/D 36,187 88,201     -
   Fuchs Henry J President, Worldwide R&D   •       –      –    2024-02-27 4 A $0.00 $0 D/D 53,204 247,458     -
   Davis George Eric EVP, Chief Legal Officer   •       –      –    2024-02-27 4 A $0.00 $0 D/D 36,187 91,897     -
   Bienaime Jean Jacques Director   –       •      –    2024-02-27 4 S $90.35 $90,350 D/D (1,000) 562,203     -
   Bienaime Jean Jacques Director   –       •      –    2024-02-27 4 A $0.00 $0 D/D 143,601 563,203     -
   Mueller Brian EVP, Chief Financial Officer   •       –      –    2024-02-27 4 A $0.00 $0 D/D 35,125 81,248     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2024-02-27 4 A $0.00 $0 D/D 37,243 98,047     -
   Bienaime Jean Jacques Director   –       •      –    2024-02-09 4 AS $88.28 $1,324,200 D/D (15,000) 419,602     -
   Bienaime Jean Jacques Director   –       •      –    2024-02-09 4 OE $63.10 $946,500 D/D 15,000 434,602     -
   Bienaime Jean Jacques Director   –       •      –    2024-02-08 4 AS $89.77 $1,346,550 D/D (15,000) 419,602     -
   Bienaime Jean Jacques Director   –       •      –    2024-02-08 4 OE $63.10 $946,500 D/D 15,000 434,602     -
   Bienaime Jean Jacques Director   –       •      –    2024-01-18 4 A $92.60 $3,704 D/D 40 419,602     -
   Bienaime Jean Jacques Director   –       •      –    2024-01-10 4 AS $96.38 $963,800 D/D (10,000) 425,162     -
   Bienaime Jean Jacques Director   –       •      –    2024-01-10 4 OE $63.10 $631,000 D/D 10,000 435,162     -
   Bienaime Jean Jacques Director   –       •      –    2024-01-09 4 AS $98.19 $981,900 D/D (10,000) 425,162     -
   Bienaime Jean Jacques Director   –       •      –    2024-01-09 4 OE $63.10 $631,000 D/D 10,000 435,162     -
   Meier Richard A Director   –       •      –    2024-01-08 4 GD $0.00 $0 D/D 3,000 112,547     -
  1285 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 52
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us